在抗MDA5抗体阳性皮肤肌炎的新疗法
Masahiro Yasui1, Taro Iwamoto, Shunsuke Furuta
1Department of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan.
Current opinion in rheumatology
|September 8, 2023
概括
对抗MDA5抗体阳性皮肤肌炎 (MDA5-DM),一种严重形式的皮肤肌炎,正在出现新的治疗方法. 虽然三重疗法显示出前景,但耐火病例需要进一步研究新型药物,如JAK抑制剂和生物药物.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 抗MDA5抗体阳性皮肤肌炎 (MDA5-DM) 呈现出快速进展的间歇性肺病和高死亡率.
- 传统的免疫抑制疗法经常失败,导致耐药病例需要新的治疗策略.
研究的目的:
- 审查MDA5-DM目前和新兴的治疗选择.
- 评估现有和新疗法的疗效和局限性.
- 为了强调需要进一步的研究来管理这种具有挑战性的条件.
主要方法:
- 对MDA5-DM治疗研究的文献综述.
- 分析传统和新型治疗方法的结果.
- 评估新兴治疗方法的证据质量.
主要成果:
- 三重组合疗法 (葡萄糖皮质类药物,氨酸抑制剂,环胺) 改善了生存率,但耐火病例仍然存在.
- 新兴的治疗方法包括雅努斯酶抑制剂,利图西马布,血交换和聚米辛B perfusion.
- 抗纤维素药物可能与免疫抑制一起提供辅助益处.
- 大多数新的治疗数据来自小型的回顾性研究,限制了最终的结论.
结论:
- 有几种MDA5-DM的新疗法可用,但最佳的治疗方案仍未确定.
- 进一步的研究和证据对于确定这些新型药物的疗效和安全性至关重要.
- 强烈的免疫抑制策略增加了感染的风险,需要仔细监测患者.
更多相关视频
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
190
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
190
01:20Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
168
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
168
01:14Myocarditis III: Medical Management
7
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
01:27Tumor Immunotherapy
554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
144
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
144